Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 889-892

  Gabrielli, Maurizio ^a   Bonazzi, Patrizia ^b   Scarpellini, Emidio ^a   Bendia, Emanuele ^b   Lauritano, Ernesto C ^a   Fasano, Alfonso ^a,c   Ceravolo, Maria G ^b   Capecci, Marianna ^b   Rita Bentivoglio, Anna ^a   Provinciali, Leandro ^b   Tonali, Pietro A ^a   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Glucose breath test; Gut flora; Parkinson's disease; Small intestinal bacterial overgrowth

Indexed keywords

LEVODOPA; PROTON PUMP INHIBITOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; BLOATING; BODY MASS; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FLATULENCE; GASTROINTESTINAL MOTILITY DISORDER; GLUCOSE BREATH TEST; HUMAN; MALE; OUTPATIENT CARE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; BACTERIAL INFECTIONS; FEMALE; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 79955103829     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23566     Document Type: Article

References (17)

1. Gasbarrini A, Lauritano EC, Gabrielli M, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis. 2007; 25: 237-240.
2. Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009; 29(Suppl 1): 1-49.
3. Barone P, Antonini A, Colosimo C, et al. PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009; 24: 1641-1649.
4. Zietz B, Lock G, Straub RH, Braun B, Schölmerich J, Palitzsch KD. Small-bowel bacterial overgrowth in diabetic subjects is associated with cardiovascular autonomic neuropathy. Diabetes Care. 2000; 23: 1200-1201.
5. Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007; 92: 4180-4184.
6. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999; 56: 33-39.
7. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003; 18: 738-750.
8. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: status and recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disord. 2004; 19: 1020-1028.
9. Thompson WG, Drossman DA, Talley NJ, et al. Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm. In: Drossman DA, Corazziari E, Delvaux M, et al, eds. ROME III, the Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates; 2006: 917-951.
10. Davies KN, King D, Billington D, Barrett JA. Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease. Postgrad Med J. 1996; 72: 164-167.
11. Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time and rectoanal videomanometry in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2003; 74: 268-272.
12. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006; 396: 67-72.
13. Phillips RJ, Walter GC, Wilder SL, Baronowsky EA, Powley TL. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's Disease? Neuroscience. 2008; 153: 733-750.
14. Pierantozzi M, Pietroiusti A, Brusa L, Galati S, et al. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology. 2006; 66: 1824-1829.
15. Lee WY, Yon WT, Shin HY, Jeon SH, Rhee PL. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease. Mov Disord. 2008; 23: 1696-1700.
16. Dobbs RJ, Dobbs SM, Weller C, et al. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter. 2008; 13: 309-322.
17. Dobbs RJ, Dobbs SM, Weller C, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic Parkinsonism. Part I: Eradication of Helicobacter in the cachexia of idiopathic parkinsonism. Helicobacter. 2005; 10: 267-275.